Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea

Diseases of the Colon and Rectum
Stuart McPhersonSimon J Panter

Abstract

Clostridium difficile diarrhea is common in elderly patients and leads to prolonged hospitalization. Patients with severe or recurrent Clostridium difficile diarrhea have poor antitoxin antibody responses. Intravenous immunoglobulin has been advocated in these patients. This study was designed to assess the response of patients with refractory, recurrent, or severe Clostridium difficile diarrhea to intravenous immunoglobulin. Retrospective review (November 2003-January 2005) of 14 patients with severe, refractory, recurrent Clostridium difficile diarrhea treated with intravenous immunoglobulin (Flebogamma, 150-400 mg/kg) from 264 Clostridium difficile toxin-positive patients. Median age was 79 (range, 54-91) years. Median length of symptoms before intravenous immunoglobulin was 29 (range, 3-90) days. Patients received a median of three (range, 1-5) courses of vancomycin or metronidazole before intravenous immunoglobulin. All had hypoalbuminemia (median, 22 g/l; range, 18-33) and raised C-reactive protein (median, 47 mg/l; range, 25-255) at time of infusion. The median white cell count was 15.3 x 10(9)/liters (range, 4-24). Eight patients had evidence of pancolitis on abdominal imaging, suggesting severe Clostridium difficile di...Continue Reading

References

Jan 1, 1984·Scandinavian Journal of Infectious Diseases·A SchwanB Aronsson
Jan 27, 1994·The New England Journal of Medicine·C P KellyJ T LaMont
Apr 2, 1998·The Journal of Hospital Infection·M H WilcoxA Davidson
Feb 10, 2000·The New England Journal of Medicine·L KyneC P Kelly
Jun 20, 2001·Gut·L Kyne, C P Kelly
Jan 5, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lorraine KyneCiarán P Kelly
Feb 1, 2002·The New England Journal of Medicine·John G Bartlett
Apr 11, 2003·Current Opinion in Infectious Diseases·Bethan Stoddart, Mark H Wilcox
Sep 26, 2003·Best Practice & Research. Clinical Gastroenterology·Christina M Surawicz

❮ Previous
Next ❯

Citations

May 20, 2008·Inflammatory Bowel Diseases·Mazen IssaDavid G Binion
Jul 17, 2008·Current Gastroenterology Reports·Thomas Mathew, Philip A Higginbottom
Dec 20, 2008·Current Infectious Disease Reports·John G Bartlett
Feb 11, 2011·Current Infectious Disease Reports·Nuntra Suwantarat, David A Bobak
Sep 2, 2011·Current Infectious Disease Reports·Suzanne Zane, Jeannette Guarner
Oct 31, 2008·The New England Journal of Medicine·Ciarán P Kelly, J Thomas LaMont
Jul 14, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John G Bartlett
Feb 7, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dale N GerdingRobert C Owens
Sep 23, 2010·Surgical Infections·Faisal Al-MufarrejFarid Gharagozloo
May 21, 2013·Journal of the Pediatric Infectious Diseases Society·Pranita D Tamma, Thomas J Sandora
Jun 30, 2007·Current Opinion in Critical Care·Sasha D Adams, David W Mercer
Sep 10, 2009·Current Opinion in Infectious Diseases·Martijn P BauerEd J Kuijper
Aug 11, 2010·Southern Medical Journal·Alan R Salkind
Sep 15, 2011·Gastroenterology Research and Practice·Preetika SinhLaura Yun
May 17, 2011·Drugs·Claire M F van Nispen tot PannerdenErnst J Kuipers
Sep 25, 2008·Future Microbiology·Lynne V McFarland
Apr 3, 2009·World Journal of Gastroenterology : WJG·Perry Hookman, Jamie S Barkin
Jan 19, 2010·World Journal of Gastroenterology : WJG·Michael J LippBrett B Bernstein
Jun 11, 2014·World Journal of Gastroenterology : WJG·Tae-Geun GweonJong Wook Lee
Jun 14, 2014·Journal of Global Infectious Diseases·Nihar ShahJack Boghossian
Apr 4, 2007·Digestive Diseases and Sciences·Rajaraman Durai
Oct 7, 2010·Digestive Diseases and Sciences·Marwan S Abougergi, John H Kwon
Mar 13, 2012·Hospital Practice·Varsha Moudgal, Jack D Sobel
Dec 17, 2008·Expert Review of Gastroenterology & Hepatology·Crenguta Stepan, Christina M Surawicz
Oct 12, 2010·Expert Review of Gastroenterology & Hepatology·Ashwin N Ananthakrishnan, David G Binion
May 23, 2012·The American Journal of Medicine·Giovanni FerraraMarkus Maeurer
Mar 22, 2012·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·David L McCollum, J Martin Rodriguez
Nov 9, 2010·Advances in Pediatrics·E Richard StiehmHeather Lehman
Dec 1, 2009·The Medical Clinics of North America·Ashwin N AnanthakrishnanDavid G Binion
Dec 30, 2008·The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·F Fitzpatrick
Nov 17, 2009·Gastroenterology Clinics of North America·Ashwin N AnanthakrishnanDavid G Binion
Aug 12, 2009·Infectious Disease Clinics of North America·David J Riddle, Erik R Dubberke
Feb 10, 2009·The Journal of Hospital Infection·D M AnthonyL Rafter
Apr 26, 2008·Surgery·Alexander J GreensteinCelia M Divino
Oct 10, 2007·Clinics in Geriatric Medicine·Chantri Trinh, Kavita Prabhakar
Jul 5, 2007·The American Journal of Geriatric Pharmacotherapy·Ali Hassoun, Farrah Ibrahim
Jun 5, 2007·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Darrell S Pardi
May 8, 2007·American Journal of Infection Control·Lynne V McFarlandGregory J Raugi
Mar 1, 2007·American Journal of Infection Control·Paul JuangRobert A Branch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.